SIMCor: In-Silico testing and validation of Cardiovascular Implantable devices
Charité – Universitätsmedizin Berlin, Berlin, Germany
The EU-funded research project SIMCor (In-Silico testing and validation of Cardiovascular Implantable devices) will create an in-silico platform and simulation tools for the development, validation and regulatory approval of cardiovascular devices, providing tangible value to patients and clinicians, device manufacturers, clinical researchers, medical authorities and regulatory bodies. The project aims to enhance the quality of medical devices released into the market, increasing their efficacy and safety, meanwhile reducing costs and time-to-market and minimising the need for live testing on animal and human subjects. High-priority safety, efficacy and usability endpoints will be investigated, focusing on device implantation and effect simulations in two representative areas: transcatheter aortic valve implantation (TAVI) and pulmonary artery pressure sensors (PAPS).
Titus Kühne
Added on: 03-17-2021
[1] https://www.charite.de/service/pressemitteilung/artikel/detail/simulationsplattform_unterstuetzt_entwicklung_medizinischer_implantate/[2] https://cordis.europa.eu/project/id/101017578[3] https://www.gesundheitsstadt-berlin.de/projekt-simcor-computersimulationen-koennen-tierversuche-reduzieren-15021/
